International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder.

Saved in:
Bibliographic Details
Title: International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder.
Authors: Downes MR; Division of Anatomic Pathology, Department of Laboratory Medicine and Molecular Diagnostics, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre.; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Lopez-Beltran A; Department of Morphological Sciences, University of Cordoba Medical School, Cordoba, Spain., Contieri R; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Milan, Italy., Hansel DE; Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Paner GP; Departments of Pathology and Surgery, Section of Urology, University of Chicago, Chicago, IL., Shen S; Department of Pathology Genomic Medicine, Houston Methodist Hospital and Weill Cornell Medical College, Houston, TX., van Rhijn BWG; Surgical Oncology (Urology), Netherlands Cancer Institute, The Netherlands., Al-Ahmadie H; Department of Pathology and Laboratory Medicine, Genitourinary Pathology Service, Memorial Sloan Kettering Cancer Center, New York, NY., Amin MB; Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.; Department of Urology, USC Keck School of Medicine, Los Angeles, CA., Brunelli M; Department of Pathology and Diagnostic, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy., Comperat E; Department of Pathology, Tenon Hospital, Sorbonne University, Paris, France.; Department of Pathology, Medical University of Vienna, Vienna, Austria., Cookson MS; The University of Oklahoma Health Sciences Center, Oklahoma City, OK., Faltas BM; Weill Cornell Medical College, New York, NY., Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Hartmann A; Institute for Pathology, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Erlangen, Germany., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX., Mertens LS; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Ross JS; Foundation Medicine, Inc., Cambridge, MA.; SUNY Upstate Medical University, Syracuse, New York, NY., van der Kwast TH; Laboratory Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Warrick J; Departments of Pathology and Urology, Penn State College of Medicine, Hershey, PA., Kristiansen G; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Cheng L; Department of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI., Raspollini MR; Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy.
Corporate Authors: Members of ISUP GU Cancer Precursor Consensus Panel
Source: The American journal of surgical pathology [Am J Surg Pathol] 2025 Dec 01; Vol. 49 (12), pp. e46-e57. Date of Electronic Publication: 2025 Jul 01.
Publication Type: Journal Article; Consensus Statement
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7707904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-0979 (Electronic) Linking ISSN: 01475185 NLM ISO Abbreviation: Am J Surg Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-0979
DOI:10.1097/PAS.0000000000002440